Global Pharmaceutical API and Intermediates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Pharmaceutical API and Intermediates market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

Pharmaceutical intermediates are also called organic pharmaceutical intermediates, which refer to a semi-finished product and are a product in the production of certain products. The raw material drug refers to the active ingredient of the drug and is also the basic substance that constitutes the pharmacological effect of the drug. API is a pharmaceutical active substance prepared through chemical synthesis, plant extraction or biotechnology.

The market for pharmaceutical raw materials and intermediates has always been a vital part of the global pharmaceutical industry. APIs are key ingredients in the pharmaceutical process, while intermediates are chemicals required in the intermediate production stages of APIs. The current status of these two markets is affected by multiple factors, including global medical needs, innovative drug development, regulations and policies, pharmaceutical company competition, etc.

This report is a detailed and comprehensive analysis for global Pharmaceutical API and Intermediates market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Pharmaceutical API and Intermediates market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031

Global Pharmaceutical API and Intermediates market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031

Global Pharmaceutical API and Intermediates market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031

Global Pharmaceutical API and Intermediates market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pharmaceutical API and Intermediates

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pharmaceutical API and Intermediates market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Patheon, Jubilant, BASF, Lianhetech, ABA Chem, Granules India, Porton, Actylis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Pharmaceutical API and Intermediates market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
API
Pharmaceutical Intermediates

Market segment by Application
Pharmaceutical
Health Products
Feed
Food
Cosmetics

Major players covered
Lonza
Catalent
Patheon
Jubilant
BASF
Lianhetech
ABA Chem
Granules India
Porton
Actylis
Pfizer
CordenPharma
Codexis
Sanofi
Chiracon
Jiuzhou Pharmaceutical
Stanley
Menohua
Tianyu shares
Puluo Pharmaceutical
Huahai Pharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pharmaceutical API and Intermediates product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Pharmaceutical API and Intermediates, with price, sales quantity, revenue, and global market share of Pharmaceutical API and Intermediates from 2020 to 2025.

Chapter 3, the Pharmaceutical API and Intermediates competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pharmaceutical API and Intermediates breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pharmaceutical API and Intermediates market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical API and Intermediates.

Chapter 14 and 15, to describe Pharmaceutical API and Intermediates sales channel, distributors, customers, research findings and conclusion.